Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Why MacroGenics (MGNX), Coherus BioSciences (CHRS) Should Be On Your Biotech Radar

    Why MacroGenics (MGNX), Coherus BioSciences (CHRS) Should Be On Your Biotech Radar

    FromSchwab Network

    Start listeningView podcast show

    Why MacroGenics (MGNX), Coherus BioSciences (CHRS) Should Be On Your Biotech Radar

    FromSchwab Network

    ratings:
    Length:
    6 minutes
    Released:
    May 12, 2021
    Format:
    Podcast episode

    Description

    Brad Loncar discusses the broader outlook for the biotech sector, on what he calls one of the best days he has seen "in ages". Two of his stocks to watch within the sector are MacroGenics and Coherus BioSciences, and he talks through some of the opportunities that lay ahead in these two names.
    Released:
    May 12, 2021
    Format:
    Podcast episode

    Titles in the series (100)

    A unique lineup of financial news and education programs, all available to stream without a subscription. Listen to industry experts track market action and interpret how it may apply to your investment portfolio. Get real-time insights, commentary, and exclusive access to CEOs, analysts, and market experts. Empowering Every Investor and Trader. Every Market Day. Produced by TD Ameritrade Media Productions Company, a wholly-owned subsidiary of TD Ameritrade Holding Corporation. TD Ameritrade Holding Corporation is a wholly owned subsidiary of The Charles Schwab Corporation. TD Ameritrade Media Productions Company is not a financial adviser, registered investment advisor, or broker-dealer. THE TD AMERITRADE NETWORK SITE, CONTENT, APPS, AND RELATED SERVICES, ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Japan, Saudi Arabia, UK, and the countries of the European Union. All TD Ameritrade Network content © TD Ameritrade Network. All rights reserved.